Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Chronic DVT ‐ antiplatelet agents plus BMP vs BMP plus placebo

Recurrent VTE · people requiring treatment for chronic DVT

Chronic DVT ‐ antiplatelet agents plus BMP may leads to lower recurrent VTE ‐ early, intermediate and long term compared with BMP plus placebo (low certainty).

1 finding from 1 review

Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes only
RR 0.65 [0.43, 0.96]
4 studies · 901 participants
Low

Chronic DVT ‐ antiplatelet agents plus BMP vs BMP alone

Recurrent VTE ‐ early and intermediate · people requiring treatment for chronic DVT

It is very uncertain whether chronic DVT ‐ antiplatelet agents plus BMP changes recurrent VTE ‐ early and intermediate compared with BMP alone (very low certainty).

1 finding from 1 review

Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes only
RR 0.12 [0.05, 0.34]
1 study · 224 participants
Very low